Aktie A203400 ABION INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Abion Inc.

Aktien

A203400

KR7203400007

A203400

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 14.05.2024 		% 5 Tage % 1. Jan.
8 380 KRW +1,33 % Intraday Chart für Abion Inc. +10,41 % -0,59 %
2023 ABION stellt neue Wirksamkeitsdaten für ABN401 vor CI
2023 Abion Inc. meldet Ergebnis für das am 31. Dezember 2022 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Abion Inc. announced that it has received KRW 7.999997049 billion in funding from TELCON RF PHARMACEUTICAL. Inc., Gencurix Inc.
TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 6 billion in funding from Abion Inc.
Gencurix Inc. announced that it has received KRW 2 billion in funding from Abion Inc.
TELCON RF PHARMACEUTICAL. Inc. announced that it expects to receive KRW 6 billion in funding from Abion Inc.
Gencurix Inc. announced that it expects to receive KRW 2 billion in funding from Abion Inc.
Abion Inc. announced that it has received KRW 8.499991272 billion in funding
Abion Inc. announced that it expects to receive KRW 8.499991272 billion in funding
ABION Presents New Efficacy Data for ABN401
Abion Inc. announced that it expects to receive KRW 21 billion in funding from LabGenomics Co., Ltd., Atinum Investment Co., Ltd, NH Investment & Securities Co., Ltd., Investment and others
Abion Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Abion Inc. Auditor Raises 'Going Concern' Doubt
Abion Inc. announced that it has received KRW 5.8 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm
Abion Inc. announced that it expects to receive KRW 5.8 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm and other investors
Abion Inc. announced that it has received KRW 7 billion in funding from Hanwha Investment & Securities Co., Ltd., MAGNA Investment Co., Ltd., Axis Investment Co., Ltd.
Abion Inc. announced that it expects to receive KRW 7 billion in funding from Hanwha Investment & Securities Co., Ltd., MAGNA Investment Co., Ltd., Axis Investment Co., Ltd.
TELCON RF PHARMACEUTICAL. Inc. acquired an additional 3.73% stake in Abion Inc. from Leeds Investments Inc. and an individual for KRW 2.8 billion.
St-Stassets Health Care Fund No.1 cancelled the acquisition of an unknown stake in Abion Inc. from KPM TECH Co., Ltd.
St-Stassets Health Care Fund No.1 and 27 other buyers acquired 32.04% stake in Abion Inc. from KPM TECH Co., Ltd. for KRW 24.4 billion.
Abion Inc. announced that it has received KRW 8.999953 billion in funding
Abion Inc. announced that it expects to receive KRW 8.999953 billion in funding
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A203400 Aktie
  4. Nachrichten Abion Inc.
  5. Andere Sprachen